The authors present a simple system for disability scoring and functional staging of an ataxic patient, based on modifications of a previous scheme advocated by De Falco and collaborators (1979). This system was tested under field conditions in 47 ataxic subjects and found to be useful and functional. RfiSUMfi: Les auteurs presentent un systeme simple pour la quantification et la classification fonctionnelle d'un patient ataxique. Ce systeme est base sur des modifications du schema publie en 1979 par De Falco et collaborateurs. Notre systeme fut verifie dans des conditions d'expe'dition sur place chez 47 patients ataxiques et trouve utile et adequat.
Two of the most difficult problems facing the clinician in the field of ataxia are those of classification and the various phenotypic presentations and quantification of the signs and symptoms observed. Such grading and staging systems have been utilized with success for disorders of the basal ganglia (Hoehn and Yahr, 1967) and have permitted the evaluation of new therapeutic approaches with objective data. Unfortunately, such systems did not exist for ataxic disorders until recently. In 1979, De Falco et al, proposed a workable system which they tested in their own patients of Southern Italy. The purpose of the present study was to test the workability of this system during investigations of ataxic patients in their homes and far from the research clinic. Experience with the De Falco scheme led to modifications which were also tested and will be detailed.
SUBJECTS AND METHODS
During a two week period in the month of July 1980, on the occasion of our yearly field investigation of ataxic patients, a total of 47 subjects (26 men; 21 women) were studied by a team of two neurologists (E.P. and A.B.). The type of ataxics involved are listed in Table One . Four patients had all the symptoms of typical Friedreich's ataxia as described by Geoffroy et al (1976) . Three suffered from what we have termed "Ataxia of Beauce" (Barbeau, 1980) . These patients had a recessive disorder characterized by gait and truncal ataxia with pyramidal tract deficits and no signs of posterior column involvement. It will be noted that, until the biochemical marker is known, we have elected to assign geographic names to the phenotypic subtypes examined. This takes into account the genetic and geographic isolate factors often encountered. Two patients had olivo-cerebellar atrophies (OPCA) of a recessive type, mainly characterized by speech disorders and gait ataxia (so called Matane type). Twenty patients suffered from a dominant form of olivo-ponto-cerebellar atrophy found in the Gaspe peninsula and previously reported by us (Wastiaux et al, 1978) . The other 18 patients were examined in Minneapolis through the courtesy of Dr. Larry Schut, during a yearly follow up clinic of the National Ataxia Foundation. They included one female patient with the Sanger-Brown variant of OPCA (spasticity and macular degeneration), two OPCA type I (Konigsmark and Weiner, 1970) from Wyoming and 15 members of the well known Schut-Swier OPCA family (Schut 1950 , Landis et al, 1974 including 5 asymptomatic at risk subjects, and 10 clear-cut ataxics.
All patients were examined at home (or at the Minneapolis Clinic) by the two neurologists working as a team. While one carried out a standard neurological examination, the other one qualified every symptom and sign on a 0 to 3 scale (0= normal, 1 = slight; 2 = moderate and 3 = severe disability) and simultaneously with the scale reported by De Falco et al (1979) . Both neurologists then decided on the functional stage to ascribe to each patient based on a scheme modified from De Falco et al (1979) and listed in Table 2 .
RESULTS AND DISCUSSION
All 47 patients kindly collaborated in this detailed examination procedure. The initial evaluation of the data was based on the exact reproduction of the scheme developed by the Italian authors. This scheme lists 26 scored items. It proved to be adequate, as can be seen in the paper by Campanella et al in this issue, but incomplete and not sufficiently discriminative. For example, some items are scored on a 0 -2 scale, and others on a 0 -4 scale, making it difficult to function in the field, without the criteria master sheet. Moreover, some items of importance in the diagnosis of certain forms of ataxia are not included, such as muscle strength, pes cavus, scoliosis, postural tremor. We were forced to add copious notes to the recording sheets to reflect the complete picture. For all these reasons we decided to prepare a new standardized grading form (Tables 3 and 4 ) which permits a discriminant analysis of major subscores: cranial nerves, coordination, tone, reflexes, peripheral signs and muscle strength. Criteria and definitions are listed in Table. 5. It should be noted that all scores are graded on a scale of 0 -3 which is probably the one offering the most familiarity to the clinician: slight, moderate and severe disability or deviation from normal. The 47 patients in our study were thus graded and the averaged results are given in Table 6 . It can be seen that there was a significant positive correlation between the total ataxia score and functional stages. A more detailed analysis of each sub-score (not reported here for lack of space but to be included in a thesis by E.P.) would reveal for example that OPCA patients have high coordination and tone scores while Friedreich's ataxia patients have very high ataxia scores coupled with maximal deviation from normal (decrease) in the tendon reflex score, severe muscle weakness scores Patient with minimal signs detected during family screening, but previously undetected and unsuspected by patient. Symptoms present, recognized by patient, but still mild. The patient is physically capable of leading an independent life, but work activities can be somewhat restricted.
Symptoms are completely developed. The patient needs help or aids to move about and transfer.
Patient is confined to wheel chair.
Patient is confined to bed.
( T a b l e 7), a n d m a r k e d p e r i p h e r a l signs scores.
We feel that this scoring and staging system is an easy, workable and reproducible scheme for objectively grading the disability of an ataxic patient, even under field conditions. We plan to use this scheme in a series of pharmacologic trials to be undertaken shortly. 
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